TOE1 is a nuclear deadenylase that functions as a 3'-to-5' exonuclease involved in the maturation of non-coding RNAs, particularly small nuclear RNAs (snRNAs) and telomerase RNA component (TERC) 1. TOE1 localizes to Cajal bodies and nucleoli, where it removes oligo(A) tails from ncRNA precursors, protecting them from degradation 2. The protein acts redundantly with PARN in processing scaRNAs and TERC, with TOE1 functioning non-redundantly in hTR 3' end processing 32. TOE1 deficiency leads to accumulation of improperly processed hTR precursors, impairing telomerase activity and shortening telomeres 3. Beyond ncRNA processing, TOE1 regulates cell growth through CDKN1A and TGF-beta expression, and emerging evidence suggests roles in hepatocellular carcinoma progression via Hippo signaling modulation 4. Loss-of-function mutations in TOE1 cause Pontocerebellar Hypoplasia type 7 (PCH7), a severe neurodegenerative disorder, where impaired ncRNA maturation leads to developmental arrest and genomic instability 15. Additionally, TOE1 functions as an HIV-1 replication inhibitor with cell-penetrating capability 6, revealing pleiotropic functions beyond classical ncRNA biogenesis.